UBS Group’s Haemonetics HAE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $70.8M | Buy |
|
|||||
|
2025
Q2 | $64.9M | Buy |
|
|||||
|
2025
Q1 | $26.4M | Buy |
|
|||||
|
2024
Q4 | $15M | Buy |
|
|||||
|
2024
Q3 | $1.93M | Buy |
|
|||||
|
2024
Q2 | $1.56M | Sell |
|
|||||
|
2024
Q1 | $4.96M | Sell |
|
|||||
|
2023
Q4 | $6.16M | Buy |
|
|||||
|
2023
Q3 | $3.98M | Sell |
|
|||||
|
2023
Q2 | $5.95M | Buy |
|
|||||
|
2023
Q1 | $4.87M | Buy |
|
|||||
|
2022
Q4 | $3.4M | Buy |
|
|||||
|
2022
Q3 | $442K | Buy |
|
|||||
|
2022
Q2 | $329K | Sell |
|
|||||
|
2022
Q1 | $1.26M | Sell |
|
|||||
|
2021
Q4 | $1.77M | Buy |
|
|||||
|
2021
Q3 | $241K | Sell |
|
|||||
|
2021
Q2 | $246K | Sell |
|
|||||
|
2021
Q1 | $2.01M | Sell |
|
|||||
|
2020
Q4 | $2.78M | Sell |
|
|||||
|
2020
Q3 | $3.19M | Buy |
|
|||||
|
2020
Q2 | $512K | Sell |
|
|||||
|
2020
Q1 | $1.15M | Sell |
|
|||||
|
2019
Q4 | $13.4M | Buy |
|
|||||
|
2019
Q3 | $6.99M | Buy |
|
|||||
|
2019
Q2 | $3.47M | Sell |
|
|||||
|
2019
Q1 | $3.41M | Sell |
|
|||||
|
2018
Q4 | $5.93M | Sell |
|
|||||
|
2018
Q3 | $7.07M | Buy |
|
|||||
|
2018
Q2 | $3.12M | Buy |
|
|||||
|
2018
Q1 | $1.05M | Buy |
|
|||||
|
2017
Q4 | $709K | Sell |
|
|||||
|
2017
Q3 | $731K | Buy |
|
|||||
|
2017
Q2 | $453K | Sell |
|
|||||
|
2017
Q1 | $516K | Sell |
|
|||||
|
2016
Q4 | $766K | Buy |
|
|||||
|
2016
Q3 | $427K | Sell |
|
|||||
|
2016
Q2 | $396K | Buy |
|
|||||
|
2016
Q1 | $353K | Buy |
|
|||||
|
2015
Q4 | $220K | Sell |
|
|||||
|
2015
Q3 | $330K | Buy |
|
|||||
|
2015
Q2 | $344K | Buy |
|
|||||
|
2015
Q1 | $239K | Buy |
|
|||||
|
2014
Q4 | $132K | Buy |
|